Compare FTLF & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTLF | PCF |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 98.6M |
| IPO Year | 2006 | 1994 |
| Metric | FTLF | PCF |
|---|---|---|
| Price | $8.85 | $5.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | 10.8K | ★ 140.3K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $21,744,000.00 | N/A |
| Revenue This Year | $30.00 | N/A |
| Revenue Next Year | $6.35 | N/A |
| P/E Ratio | $23.51 | ★ N/A |
| Revenue Growth | ★ 11.52 | N/A |
| 52 Week Low | $8.50 | $4.95 |
| 52 Week High | $20.77 | $6.35 |
| Indicator | FTLF | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 29.85 |
| Support Level | $8.79 | $4.95 |
| Resistance Level | $9.74 | $5.63 |
| Average True Range (ATR) | 0.29 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 61.29 | 25.02 |
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.